Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shot up 7.3% during mid-day trading on Thursday . The company traded as high as $1.08 and last traded at $0.97. 1,343,839 shares changed hands during trading, an increase of 98% from the average session volume of 680,343 shares. The stock had previously closed at $0.91.
Curaleaf Stock Performance
The company has a market capitalization of $586.03 million, a price-to-earnings ratio of -3.05 and a beta of 0.95. The company has a 50 day moving average price of $0.98 and a 200 day moving average price of $1.60. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 1.11.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.02 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.09. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%. The firm had revenue of $331.05 million during the quarter, compared to analysts' expectations of $331.87 million. Equities research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.
Curaleaf Company Profile
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
